A Phase 2, Multi-Center, Randomized, Evaluator-Blinded, Vehicle-Controlled Study Comparing the Efficacy, Tolerability, and Safety of SB204 Gel and Vehicle Gel Once or Twice Daily in the Treatment of Acne Vulgaris

Trial Profile

A Phase 2, Multi-Center, Randomized, Evaluator-Blinded, Vehicle-Controlled Study Comparing the Efficacy, Tolerability, and Safety of SB204 Gel and Vehicle Gel Once or Twice Daily in the Treatment of Acne Vulgaris

Completed
Phase of Trial: Phase II

Latest Information Update: 10 Jan 2017

At a glance

  • Drugs Nitric oxide (Primary)
  • Indications Acne vulgaris
  • Focus Therapeutic Use
  • Sponsors Novan Inc
  • Most Recent Events

    • 18 Oct 2016 According to a Novan Therapeutics media release, results from this trial will be presented at the 35th Anniversary Fall Clinical Dermatology Conference
    • 28 Sep 2016 Results from this trial presented at the 74th Annual Meeting of the American Academy of Dermatology in March, as per Novan media release.
    • 01 Mar 2016 According to a Novan Therapeutics media release, results from this trial will be presented at the 74th Annual Meeting of the American Academy of Dermatology ("AAD")
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top